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Plasmodium knowlesi, a simian malaria parasite responsible for all recent indigenous cases of 
malaria in Malaysia, infects humans throughout Southeast Asia. There are two genetically distinct 
subpopulations of Plasmodium knowlesi in Malaysian Borneo, one associated with long-tailed 
macaques (termed cluster 1) and the other with pig-tailed macaques (cluster 2). A prospective study 
was conducted to determine whether there were any between-subpopulation differences in clinical 
and laboratory features, as well as in epidemiological characteristics. Over 2 years, 420 adults 
admitted to Kapit Hospital, Malaysian Borneo with knowlesi malaria were studied. Infections with 
each subpopulation resulted in mostly uncomplicated malaria. Severe disease was observed in 35/298 
(11.7%) of single cluster 1 and 8/115 (7.0%) of single cluster 2 infections (p = 0.208). There was no 
clinically significant difference in outcome between the two subpopulations. Cluster 1 infections were 
more likely to be associated with peri-domestic activities while cluster 2 were associated with interior 
forest activities consistent with the preferred habitats of the respective macaque hosts. Infections 
with both P. knowlesi subpopulations cause a wide spectrum of disease including potentially life-
threatening complications, with no implications for differential patient management.
The simian malaria parasite, Plasmodium knowlesi was found to be the commonest cause of human malaria 
infections in the Kapit Division of Sarawak, Malaysian Borneo in  20041. Subsequent studies have shown that 
zoonotic malaria cases occur throughout Southeast Asia and in the Andaman and Nicobar islands of  India2–5. The 
highest incidence is in Malaysia, where 13,612 knowlesi malaria cases were reported between 2017 to 2020, with 
87% from the Malaysian Borneo states of Sabah and Sarawak (B. Singh, unpublished data). All the indigenous 
malaria cases in Malaysia in 2018 and 2019 were due to P. knowlesi6. Human knowlesi malaria infections have 
been increasing in Malaysia since they were first reported in  20041. From the 120 cases detected in Sarawak over 
a 32-month period at that  time1, the annual number of reported cases in Malaysia has increased to 912 in 2009, 
and to between 1600 and 4131 since  20127. This increase may reflect improved diagnostic capacity, decrease in 
cross-species immunity due to decrease in malaria caused by human malaria species, and increased interaction 
between humans, macaques and mosquito vectors. This latter explanation is based on land-use changes leading 
to alterations in mosquito abundance and composition, and to greater proximity of the movement of the reservoir 
macaque hosts to human  habitation7,8. The increase in zoonotic malaria cases is of public health concern and a 
threat to the elimination of malaria.
Micro-satellite genotyping of P. knowlesi isolates from wild macaques in Kapit, Malaysian Borneo and humans 
across Malaysia has identified two simian host-associated genetically distinct  subpopulations9. Two-thirds of 
human infections were of one subpopulation (termed cluster 1) associated with long-tailed macaques (Macaca 
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